STARD3: A Prospective Target for Cancer Therapy
Cancer is one of the major causes of death in developed countries and current therapies are based on surgery, chemotherapeutic agents, and radiation. To overcome side effects induced by chemo- and radiotherapy, in recent decades, targeted therapies have been proposed in second and even first lines....
Main Authors: | Kanwal Asif, Lorenzo Memeo, Stefano Palazzolo, Yahima Frión-Herrera, Salvatore Parisi, Isabella Caligiuri, Vincenzo Canzonieri, Carlotta Granchi, Tiziano Tuccinardi, Flavio Rizzolio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/18/4693 |
Similar Items
-
Human StarD5, a cytosolic StAR-related lipid binding protein
by: Daniel Rodriguez-Agudo, et al.
Published: (2005-08-01) -
ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes
by: Daniel Rodriguez-Agudo, et al.
Published: (2012-12-01) -
Thirty-eight-year follow-up of two sibling Lipoid Congenital Adrenal Hyperplasia patients due to homozygous Steroidogenic Acute Regulatory (STARD1) protein Mutation. Molecular structure and modeling of the STARD1 L275P mutation.
by: Jean-Guy Lehoux
Published: (2016-11-01) -
Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation*
by: Daniel Rodriguez-Agudo, et al.
Published: (2008-07-01) -
Quality Assessment of Research Articles in Nuclear Medicine Using STARD and QUADAS-2 Tools
by: Krisana Roysri, et al.
Published: (2014-10-01)